MLTX
MLTX
NASDAQ · Biotechnology

Moonlake Immunotherapeutics

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$18.86
+1.80 (+10.55%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 18 78%
Hold 3 13%
Sell 2 9%
Price Target
Analyst Price Target -44.1% upside
Low Target $8.06
Average Target $10.54
High Target $16.98
Current Price $18.86
Current
$18.86
Target
$10.54
$8.06 $10.54 avg $16.98
Scenario Analysis
Bear Case
$8.06
-57.3%
Low target
Base Case
$10.54
-44.1%
Avg target
Bull Case
$16.98
+-10.0%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$62.75
-69.9% from high
52-Week Low
$5.95
+217.0% from low
Target vs 52W High
$10.54
-83.2% vs high
Next Earnings Report
May 11, 2026 · Before Market Open
Today
EPS Est: $-0.91
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%